|
|
2022, Vol. 31(9): 778-784 DOI: 10.3760/cma.j.cn113030-20210901-00336 |
|
|
|
The strategy and feasibility of dose optimization in clinical target volume Ⅱb in patients with N0‐N1 nasopharyngeal carcinoma |
|
|
Huang Wenxuan1, Zong Dan1, Zhang Bin1, Wang Lijun1, Zhang Lanfan2, Ma Chengxian1, Yin Li1, Huang Shengfu1, He Xia1 |
|
|
1Department of Radiation Oncology, Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 210009, China;
2Department of Medical Imaging, Jiangsu Cancer Hospital, Nanjing 210009, China |
|
|
Received 2021-09-01 Revised null |
|
|
Supporting info |
|
|
|
|
|
|
null |
|
|
